XLV is trading 3% up now at $168.33 as strong Q2 earnings and a rotation into defensive sectors drive a sharp outperformance against the broader market.
- Key holdings including Centene and HCA Healthcare reported robust Q2 results and raised forward guidance, fueling the sector-wide rally.
- Hedge fund exposure to U.S. healthcare has reached a multi-year high as investors pivot away from semiconductors and growth stocks in favor of value and defensives.